Casdin Capital, LLC Homology Medicines, Inc. Transaction History

Casdin Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $9.36 Million - $18.2 Million	-820,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $1.11 Million - $1.67 Million	75,000 Added 10.07%	820,000 $14.8 Billion
Q2 2019 Aug 13, 2019	BUY	$18.35 - $30.34 $7.25 Million - $12 Million	395,000 Added 112.86%	745,000 $0
Q3 2018 Nov 14, 2018	BUY	$15.54 - $22.86 $3.65 Million - $5.37 Million	235,000 Added 204.35%	350,000 $8 Million
Q2 2018 Aug 14, 2018	BUY	$16.49 - $21.55 $906,949 - $1.19 Million	55,000 Added 91.67%	115,000 $2.35 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $1.12 Million - $1.12 Million	60,000 New	60,000 $1.12 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.